Experts call for name change of vaping lung illness

Sep.29.2022
Experts call for name change of vaping lung illness
75 experts request to change the name of a disease related to lung injuries caused by e-cigarettes due to misleading implications.

Due to the inherent possibility of electronic cigarettes causing related lung injuries, approximately 75 multidisciplinary experts have requested the Centers for Disease Control and Prevention to change the name of the illness, as it is misleading and incorrectly implies that all e-cigarette devices can cause this illness, when in fact the only confirmed cause is THC e-cigarette products contaminated with vitamin E acetate.


In 2019, the UK Department of Public Health stated that EVALI was not related to the long-term use of regulated nicotine e-cigarette products. As a result of a rapid public health response, there has been increased awareness among the public about the risks associated with using e-cigarettes or e-cigarette products containing THC.


However, the Centers for Disease Control and Prevention (CDC) emphasized that there is insufficient evidence to rule out the possibility of other chemicals potentially playing a role in EVALI cases, including chemicals from products containing or not containing THC. Research data on e-cigarette products reveal thousands of chemical components, the majority of which remain unidentified.


Dr. Mendelsohn’s research has further indicated that erroneous information about the relationship between e-cigarettes and EVALI could have deadly consequences. He emphasizes the need to correct the ongoing misunderstandings about the cause of EVALI, as incorrect information could lead to public panic and harm public health, not only in Australia, but also in the United States.


Medical experts and public health regulatory agencies around the world have discovered that electronic cigarettes are the most popular aid for quitting or reducing smoking. As a result, they can help smokers transition to better alternatives.


In fact, the public health benefits of electronic cigarettes have been recognized by the National Health Service in the UK and the Ministry of Health in New Zealand, as they have accepted the use of electronic cigarettes to help smokers quit their habit.


The UK government has expressed concern that unfounded fears about electronic cigarettes are preventing smokers from using them as a tool to quit smoking. Similarly, New Zealand's Ministry of Health has launched a public campaign aiming to dispel misconceptions surrounding e-cigarettes and encourage smokers to incorporate them as part of the country's smoke-free 2025 goal.


The US Centers for Disease Control and Prevention (CDC) has recommended that those attempting to quit smoking using e-cigarettes weigh the benefits and risks and avoid using e-cigarettes that contain THC, any kind of modified e-cigarette device, or any substance not approved by the US government. As public health authorities and the general public increasingly recognize the science behind e-cigarettes and support their adoption through thoughtful and balanced regulatory frameworks, e-cigarettes will continue to play a crucial role in helping smokers quit around the world.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS, nor can 2FIRSTS confirm the authenticity or accuracy of its content. The translation of this article is solely for communication and research purposes within the industry.


Due to limitations in translation proficiency, the translated article may not fully reflect the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao or Taiwan-related, or foreign-related remarks and stances.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.
Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.
Altria reported Q3 2025 net revenue of $6.072 billion, a 3.0% year-on-year decline. Adjusted EPS increased 3.6% to $1.45. The company expanded its share repurchase program to $2 billion and launched the on!PLUS nicotine pouch in Florida, North Carolina, and Texas.
Oct.31 by 2FIRSTS.ai
Alaska Settles with Juul and Altria for $7.8 Million After Five-Year Lawsuit
Alaska Settles with Juul and Altria for $7.8 Million After Five-Year Lawsuit
The State of Alaska has reached a $7.8 million settlement with e-cigarette maker Juul and its investor Altria, concluding a five-year lawsuit alleging the companies targeted Alaskan youth with nicotine products.
Dec.08 by 2FIRSTS.ai
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Trading Ltd., a subsidiary of British American Tobacco (BAT), has won an appeal at the European Patent Office (EPO), convincing the appellate board that examiners had violated its right to be heard by failing to review all of its submissions.
Dec.09 by 2FIRSTS.ai
China Boton Group Resumes Trading, Soars 55.56% to 52-Week High; Signs Land Acquisition Agreement with Shenzhen Government - Reuters/AP
China Boton Group Resumes Trading, Soars 55.56% to 52-Week High; Signs Land Acquisition Agreement with Shenzhen Government - Reuters/AP
China Boton Group (HK.3318) resumed trading on December 10, opening at 2.800 HKD and surging 55.56%.
Dec.10 by 2FIRSTS.ai
Special Report| Vuse Gains as U.S. Cracks Down on Illegal Vapes, But a $590 Million China Export Shadow Looms
Special Report| Vuse Gains as U.S. Cracks Down on Illegal Vapes, But a $590 Million China Export Shadow Looms
The payoff is here: BAT’s Vuse has seized a rare regulatory vacuum to reverse its U.S. slide, capitalizing on a crackdown that seemingly compressed the illicit market to 54%. But the victory is fragile. A record $590 million export shock in October signals the gray market is striking back—pitting a fleeting compliance dividend against a massive inventory wall.
BAT
Dec.09
Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series
Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series
Miracle’s heated tobacco brand REJO has launched its new device REJO CUBE in Dubai. The device’s industrial design is highly similar to the ELFBAR JOINOne series, featuring a left-right magnetic structure and side-mounted screen. Positioning the Middle East as a key market, REJO is moving ahead with local team building and entity setup in the region.
Nov.14 by 2FIRSTS.ai